Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
| Revenue (Most Recent Fiscal Year) | $22.59B |
| Net Income (Most Recent Fiscal Year) | $2.99B |
| PE Ratio (Current Year Earnings Estimate) | 29.47 |
| PE Ratio (Trailing 12 Months) | 31.41 |
| PEG Ratio (Long Term Growth Estimate) | 2.97 |
| Price to Sales Ratio (Trailing 12 Months) | 6.47 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 7.18 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 26.09 |
| Pre-Tax Margin (Trailing 12 Months) | 14.35% |
| Net Margin (Trailing 12 Months) | 12.31% |
| Return on Equity (Trailing 12 Months) | 23.74% |
| Return on Assets (Trailing 12 Months) | 11.25% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.64 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.00 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.69 |
| Inventory Turnover (Trailing 12 Months) | 1.66 |
| Book Value per Share (Most Recent Fiscal Quarter) | $54.13 |
| Earnings per Share (Most Recent Fiscal Quarter) | $2.84 |
| Earnings per Share (Most Recent Fiscal Year) | $12.19 |
| Diluted Earnings per Share (Trailing 12 Months) | $7.40 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 381.69M |
| Free Float | 361.84M |
| Market Capitalization | $150.21B |
| Average Volume (Last 20 Days) | 1.13M |
| Beta (Past 60 Months) | 0.91 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 5.20% |
| Percentage Held By Institutions (Latest 13F Reports) | 77.09% |
| Annual Dividend (Based on Last Quarter) | $3.36 |
| Dividend Yield (Based on Last Quarter) | 0.85% |